New Zealand markets close in 3 hours 17 minutes

Dr. Reddy's Laboratories Limited (DRREDDY.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
6,073.95+6.50 (+0.11%)
At close: 03:47PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 1.01T
Enterprise value 949.02B
Trailing P/E 18.16
Forward P/E 21.10
PEG ratio (5-yr expected) 3.67
Price/sales (ttm)3.62
Price/book (mrq)3.60
Enterprise value/revenue 3.40
Enterprise value/EBITDA 10.73

Trading information

Stock price history

Beta (5Y monthly) 0.30
52-week change 320.78%
S&P500 52-week change 324.96%
52-week high 36,505.50
52-week low 35,005.00
50-day moving average 35,996.79
200-day moving average 35,859.76

Share statistics

Avg vol (3-month) 316.4k
Avg vol (10-day) 316.18k
Shares outstanding 5166.54M
Implied shares outstanding 6166.54M
Float 8119.93M
% held by insiders 129.03%
% held by institutions 147.96%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 440
Forward annual dividend yield 40.66%
Trailing annual dividend rate 340.00
Trailing annual dividend yield 30.66%
5-year average dividend yield 40.62
Payout ratio 411.98%
Dividend date 3N/A
Ex-dividend date 415 Jul 2024
Last split factor 22:1
Last split date 328 Aug 2006

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.95%
Operating margin (ttm)18.31%

Management effectiveness

Return on assets (ttm)11.51%
Return on equity (ttm)21.77%

Income statement

Revenue (ttm)279.16B
Revenue per share (ttm)1,677.73
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)N/A
EBITDA 79.01B
Net income avi to common (ttm)55.68B
Diluted EPS (ttm)334.32
Quarterly earnings growth (yoy)36.30%

Balance sheet

Total cash (mrq)81.47B
Total cash per share (mrq)489.23
Total debt (mrq)20.02B
Total debt/equity (mrq)7.14%
Current ratio (mrq)2.58
Book value per share (mrq)1,684.70

Cash flow statement

Operating cash flow (ttm)45.43B
Levered free cash flow (ttm)12.23B